Rare Journeys
Real Impact

Providing bespoke end-to-end commercialisation solutions for rare disease innovators launching medicines in Europe.

A selection of our trusted partners

A complete end-to-end solution made for the rare disease product lifecycle

Market Access

  • Market Access Strategy
  • Health Economics & Outcomes Research (HEOR)
  • Submission Management
Learn More

Medical Affairs

  • Medical Strategy
  • Key Opinion Leader (KOL) Engagement
  • Medical Events
Learn More

Strategy & Marketing

  • Go To Market Strategy
  • Launch Execution
  • Marketing Solutions
  • Marketing Compliance
Learn More

Commercial Services

  • Commercial Field Force
  • Tender Management
  • Local Market Insights
Learn More

Regulatory & Tech Services

  • Regulatory
  • Drug Safety
  • Medical Information
  • Quality
  • Technical Compliance
Learn More

Supply Chain Management

  • Commercial Distribution
  • Inventory Management
  • Good Manufacturing Practices (GMP) Packaging Services
Learn More

Analytics & Insights

  • Competitive Intelligence
  • Stakeholder Mapping
  • Reporting
Learn More

Designed for biotech and pharmaceutical firms, our innovative commercialisation solution simplifies the complex issues involved in multi-market drug launches.

Rare diseases focus

We drive treatment access for conventionally underserved patient groups with high unmet needs.

European footprint

We deliver market knowledge and infrastructure to launch products in over 16 European markets.

Tailored solutions

We combine decades of industry experience from big pharma to life science consultancy.

Deep expertise

We scope each program to align with the unique requirements and strategy of our partners.

Novel therapies

Accelerate launch trajectories

A comprehensive suite of services designed specifically to support the end-to-end commercialisation needs of biotech and pharmaceutical companies focused on orphan drug development.

Established brands

Optimise multi-market operations

A selection of services to enable secure access to local markets in a time and resource-efficient manner, including multi-market tender and supply chain management.

16
Markets across Europe
11
Life-changing therapies
7
Partners and counting

Ready to take the next step?

Let us share how we could successfully support your product commercialisation.

Therapeutic areas

Genetic & Metabolic Disorders

Our commercialisation expertise spans a range of genetic & metabolic disorders and conditions.

Haematology & Oncology

Within haematology, we work with products and therapies serving a handful of key rare diseases.

CNS & Neurology

Our experience also extends to rare, hereditary disorders affecting the central nervous system.

Latest insights

Stay abreast of key issues and critical thinking within the European rare disease community.

Pharma commercialization strategies: A blueprint for launching a new product in Europe
Medical affairs challenges for orphan drugs: the key to a winning KOL engagement strategy
How real-world evidence is changing Health Technology Assessment (HTA) submissions